Medical Disclaimer

Last updated: October 19, 2026

Retatrutide is not an FDA-approved medicine.It is an investigational compound developed by Eli Lilly and Company and is still being studied in clinical trials. It has not been approved by the U.S. Food and Drug Administration for weight loss, diabetes or any other use.

No medical advice

The content on RetaRate — including vendor rankings, reviews, research summaries and news — is provided for general informational purposes only. It is not medical advice, diagnosis or treatment, and it is not a substitute for advice from a licensed physician or pharmacist. Never disregard professional medical advice or delay seeking it because of something you read on this website.

Research-use products

Vendors reviewed on this site sell retatrutide and other peptides as research chemicals labeled for laboratory research use only and "not for human consumption." Such products are not manufactured, inspected or approved as drugs, and their identity, purity, sterility and dosage cannot be guaranteed by RetaRate. Certificates of analysis (COAs) published by vendors are vendor-supplied documents; we report whether they exist, not whether every vial matches them.

No dosing information

We do not provide dosing, reconstitution-for-injection or self-administration guidance. Dose levels mentioned in our research articles describe what was given to participants in published clinical trials under medical supervision.

Approved alternatives

If you are considering a medicine for weight management or type 2 diabetes, talk to a licensed healthcare provider about FDA-approved options and whether they are appropriate for you.

Emergencies

If you think you may have a medical emergency, call 911 or your doctor immediately.